Related Experiment Video
Updated: May 19, 2026

Fluorescence-Based Measurements of Phosphatidylserine/Phosphatidylinositol 4-Phosphate Exchange Between Membranes
Published on: March 14, 2021
The expression of dual-specificity phosphatase 1 mRNA is downregulated in lesional psoriatic skin
R B Kjellerup1, C Johansen, K Kragballe
1Department of Dermatology, Aarhus University Hospital, P.P. Oerumsgade 11, 8000 Aarhus C, Denmark.
Background:
The p38 mitogen-activated protein kinase (MAPK) plays an important role in inflammatory processes and displays increased activity in psoriasis. Dual-specificity phosphatase 1 (DUSP1) is an important negative regulator of p38 MAPK activity.
Objectives:
To study mRNA expression of DUSP1 in normal human epidermal keratinocytes (NHEKs) stimulated with proinflammatory cytokines and to investigate DUSP1 in psoriatic skin.
Methods:
NHEKs were cultured in vitro and punch biopsies were obtained from the skin of patients with psoriasis vulgaris and atopic dermatitis. mRNA expression was analysed by reverse transcription-quantitative polymerase chain reaction (RT-qPCR).
Results:
In NHEKs, interleukin (IL)-1β induced DUSP1 mRNA expression in a rapid and time-dependent manner through the p38 MAPK/mitogen- and stress-activated kinase (MSK) signalling pathway. DUSP1 mRNA expression was demonstrated to be significantly downregulated in psoriatic skin lesions compared with paired samples of nonlesional psoriatic skin. This was in contrast to atopic dermatitis. The downregulation of DUSP1 mRNA in lesional psoriatic skin was not explained by the difference in the mRNA expression of the potential DUSP1 transcript stability-affecting proteins Hu antigen R or tristetraprolin. Furthermore, DUSP1 mRNA expression was shown not to increase during the early course of treatment with the antitumour necrosis factor-α antibody adalimumab.
Conclusions:
In lesional psoriatic skin, the p38 MAPK negative feedback mechanism provided by DUSP1 seems to be inhibited. Downregulation of DUSP1 may contribute to the sustained inflammatory response seen in psoriasis.
Insights
Dual-specificity phosphatase 1 (DUSP1) is downregulated in psoriasis, impairing the p38 MAPK pathway. This reduced DUSP1 expression in psoriatic skin may drive persistent inflammation.
Area of Science:
- Dermatology
- Molecular Biology
- Immunology
Background:
- Psoriasis involves heightened p38 mitogen-activated protein kinase (MAPK) activity.
- Dual-specificity phosphatase 1 (DUSP1) normally inhibits p38 MAPK signaling.
- Understanding DUSP1's role is crucial for psoriasis pathogenesis.
Purpose of the Study:
- Investigate DUSP1 mRNA expression in normal human epidermal keratinocytes (NHEKs) stimulated by cytokines.
- Analyze DUSP1 mRNA levels in psoriatic skin lesions.
- Explore the relationship between DUSP1 and p38 MAPK in psoriasis.
Main Methods:
- Cultured NHEKs and analyzed mRNA expression via RT-qPCR.
- Obtained skin biopsies from patients with psoriasis vulgaris and atopic dermatitis.
- Assessed DUSP1 mRNA expression in lesional and non-lesional psoriatic skin.
Main Results:
- Interleukin-1β rapidly induced DUSP1 mRNA in NHEKs via the p38 MAPK/MSK pathway.
- DUSP1 mRNA was significantly downregulated in psoriatic lesions compared to non-lesional skin.
- DUSP1 mRNA did not increase with adalimumab treatment in early stages.
Conclusions:
- The p38 MAPK negative feedback loop involving DUSP1 appears inhibited in lesional psoriatic skin.
- Reduced DUSP1 expression may contribute to sustained inflammation in psoriasis.
- DUSP1 downregulation is specific to psoriatic lesions, unlike atopic dermatitis.
Related Concept Videos
Abnormal Proliferation
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
The JAK-STAT Signaling Pathway
GPCR Desensitization
Pleiotropy
